Market Value4,802,152,628
Total Holdings60
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
/ Third Harmonic Bio, Inc.
PTGX / Protagonist Therapeutics, Inc.
AXNX / Axonics, Inc.
/ JASPER THERAPEUTICS INC
SUMMIT HEALTHCRE ACQUISTN CO / UNIT 06/03/2026 (G8566R128)
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
KYG5960S1241 / Medicus Sciences Acquisition Corp.
TELA / TELA Bio, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
NYXH / Nyxoah SA
CINC / CinCor Pharma Inc
LSAQ / LifeSci Acquisition II Corp
/ Nautilus Biotechnology Inc
ARYE / ARYA Sciences Acquisition Corp V - Class A
MSAC / Medicus Sciences Acquisition Corp - Class A
NTRA / Natera, Inc.
CCCC / C4 Therapeutics, Inc.
LUNG / Pulmonx Corporation
ROIV / Roivant Sciences Ltd.
AVDL / Avadel Pharmaceuticals plc
AADI / Aadi Bioscience, Inc.
RNA / Avidity Biosciences, Inc.
OBIO / Orchestra BioMed Holdings, Inc.
AXSM / Axsome Therapeutics, Inc.
XGN / Exagen Inc.
GHRS / GH Research PLC
ACAD / ACADIA Pharmaceuticals Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
VCEL / Vericel Corporation
TXG / 10x Genomics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
ACET / Adicet Bio, Inc.
PMVP / PMV Pharmaceuticals, Inc.
MASI / Masimo Corporation
FULC / Fulcrum Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
MASS / 908 Devices Inc.
CLDX / Celldex Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
YS / LakeShore Biopharma Co., Ltd
RGNX / REGENXBIO Inc.
MRTX / Mirati Therapeutics, Inc.
JNCE / Jounce Therapeutics Inc
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
MIST / Milestone Pharmaceuticals Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
DMTK / DermTech, Inc.
MIRO / Miromatrix Medical Inc
ALLK / Allakos Inc.
OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
JNJ / Johnson & Johnson
TNYA / Tenaya Therapeutics, Inc.
PEN / Penumbra, Inc.
MLTX / MoonLake Immunotherapeutics
ISEE / IVERIC bio Inc
HSAQ / Health Sciences Acquisitions Corp 2
CYTK / Cytokinetics, Incorporated
IMUX / Immunic, Inc.
IMTX / Immatics N.V.
OYST / Oyster Point Pharma Inc
BRKR / Bruker Corporation
CSTL / Castle Biosciences, Inc.
RXDX / Prometheus Biosciences Inc
SGHT / Sight Sciences, Inc.
ILMN / Illumina, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
TMO / Thermo Fisher Scientific Inc.
GH / Guardant Health, Inc.
SCPH / scPharmaceuticals Inc.
/ VENTYX BIOSCIENCES INC
OM / Outset Medical, Inc.
VKTX / Viking Therapeutics, Inc.
AKYA / Akoya Biosciences, Inc.
URGN / UroGen Pharma Ltd.
RCKT / Rocket Pharmaceuticals, Inc.
GMED / Globus Medical, Inc.
STOK / Stoke Therapeutics, Inc.
MLYS / Mineralys Therapeutics, Inc.
CUTRQ / Cutera, Inc.
PTCT / PTC Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
APYX / Apyx Medical Corporation
ESTA / Establishment Labs Holdings Inc.